Frequently Bought Together
Dextran sulfate sodium salt (DSS) is a polyanionic derivative of dextran produced by the esterification of Dextran with chlorosulphonic acid. The sulfur content is approximately 17% which corresponds to an average of 1.9 sulfate groups per glucosyl residue of the dextran molecule. DSS has several characteristics: 1) polyanionic complex, soluble in water, forming a colorless aqueous solution; 2) high purity and good stability; 3) can be degraded naturally. Inflammatory bowel disease (IBD) is a chronic, relapsing gastrointestinal infection that increases the risk of intestinal tumors, mainly including UC and Crohn disease (CD). In 1985, after the hamster ulcerative colitis model was first prepared by using DSS, a large number of studies have proved that the DSS colitis model is similar to human ulcerative colitis. The histological features, clinical manifestations, disease site, and cytokine proliferation of the DSS colitis model are very similar to human ulcerative colitis (UC). The modeling conditions and operation methods of this model are simple, the expenditure is very cheap, the repeatability is good, and it is easy to master and popularize. The DSS concentration and dosing time can be adjusted according to the experimental purpose to establish acute, chronic, and acute-chronic alternation models.
Features
High purity, water-soluble, and stable – forms a clear aqueous solution with reliable quality.
Biodegradable – naturally degradable, safe for long-term studies.
Easy to use – simple protocols with high repeatability.
Versatile UC model induction – dose-dependent UC symptoms, closely resembling human UC.
Multi-species applicability – effective in mice, rats, zebrafish, pigs, fruit flies, etc.
Widely used in IBD/CAC research – especially suitable for colitis and colitis-associated cancer models (with AOM).
Applications
For modeling colitis
Specifications
| English synonym | Dextran Sulfate Sodium Salt, DSS; Dextran Sodium Sulfate |
| CAS NO. | 9011-18-1 |
| Formula | (C6H7Na3O14S3)n |
| Appearance | White or off-white powder |
| Solubility | Soluble in water, slightly soluble in ethanol. |
| Structure | ![]() |
Components
| Components No. | Name |
60316ES10
|
60316ES25 | 60316ES60 | 60316ES76 | 60316ES80 |
| 60316 | Dextran Sulfate Sodium Salt (DSS) MW:36000~50000 |
10 g
|
25 g | 100 g | 500 g | 1 kg |
Figures

Figure 1 H&E staining results of DSS acute colitis sections[1]
Animal: BALB/c mice, female, 6-8 weeks, 25 g; Method: 3.5% DSS for 7 days

Figure 2 H&E staining results of colitis-associated cancer sections[2]
Animal: BALB/c mice, male,7 weeks old; DSS concentration: 2.5%; AOM concentration:10 mg/kg; Experiment period:10 weeks
*Links to this resource:
[1]Gao X, Fan W, Tan L, et al. Soy isoflavones ameliorate experimental colitis by targeting ERα/NLRP3 inflammasome pathways[J]. The Journal of Nutritional Biochemistry, 2020, 83.
[2]Jia-Rong Huang, et al. Piperlongumine Alleviates Mouse Colitis and Colitis-Associated Colorectal Cancer[J]. Frontiers in Pharmacology. 2020.586885
Storage
FAQ
1. The bottle cap was blocked;
2. Some mice did not drink/a small amount of DSS. Suggestions: 1. Check the mouse drinking bottle every day; 2. Each mouse is isolated and cultured separately, and the water intake of the mice is checked every day or the mice are pre-raised for 1-2 weeks after arrival, and the mice with abnormal water intake are excluded.
Citations
Documents
Applications
You may also like
Inquiry
FAQ
The product is for research purposes only and is not intended for therapeutic or diagnostic use in humans or animals. Products and content are protected by patents, trademarks, and copyrights owned by Yeasen Biotechnology. Trademark symbols indicate the country of origin, not necessarily registration in all regions.
Certain applications may require additional third-party intellectual property rights.
Yeasen is dedicated to ethical science, believing our research should address critical questions while ensuring safety and ethical standards.




